Premium
Resolution of methylphenidate osmotic release oral system‐induced hair loss in two siblings after dose escalation
Author(s) -
Ardic Ulku Akyol,
Ercan Eyup Sabri
Publication year - 2017
Publication title -
pediatrics international
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.49
H-Index - 63
eISSN - 1442-200X
pISSN - 1328-8067
DOI - 10.1111/ped.13414
Subject(s) - medicine , resolution (logic) , methylphenidate , anesthesia , pharmacology , psychiatry , attention deficit hyperactivity disorder , artificial intelligence , computer science
This report describes the cases of two siblings who experienced hair loss after treatment with methylphenidate ( MPH ) osmotic release oral system ( OROS ). Hair loss was resolved after discontinuation of the drug, but the children re‐initiated treatment, after which hair loss again occurred, but they continued the treatment. After dose escalation, the hair loss resolved. This is the first report to describe resolution of OROS ‐ MPH ‐induced hair loss after dose escalation.